The International Journal of Drug Development and Research (IJDDR) is an international peer review quarterly, scientific and professional journal emphasizing quality pharmaceutical discoveries and innovations. International Journal of Drug Development and Research (IJDDR) provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Sciences & Technology. International Journal of Drug Development and Research (IJDDR) publishes full length research reports, review articles,and scientific commentaries & communication on all aspects of the pharmaceutical sciences with strong sciences with strong emphasis on novelty, originality and scientific quality. The Editors welcome articles in this multidisciplinary field, ranging from Drug Development to Drug Discovery. More specifically, the Journal publishes reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery systems including gene delivery, drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Manuscripts submitted to the Journal are only accepted on the understanding that they are subject to editorial review process generally single blind review.
The drugs which are used to control the growth of cancerous cells are called anticancer drugs. The process of bringing a new drug which controls the growth of cancerous cells into the market after lead compound has been discovered with the process of drug discovery is called Anticancer drug development.
The process of bringing a new pharmaceutical drug into the market once a lead compound has been identified through the process of drug discovery is called drug development and the research related to drug development is called drug development research.
Generic drug is the drug which is defined as a drug product which is comparable to reference drug listed in strength, dosage form, quality, characteristics and use. The key steps involved in Generic product development include the utilization of reference product for the designing of a pharmaceutically bioequivalent and equivalent product.
The stage of research that begins before the clinical trials can start during which drug safety data, important feasibility and testing is done is called preclinical drug development. Main aim of this is to determine the safe dose.
Structure-based drug design is the idea which represents that we can see exactly how the molecule interacts with the target protein, specializing in structure-based drug design focuses on the only one method of determination of structure. Structure-based drug design is most powerful when it is coupled with combinatorial techniques.
The different phases of drug development include preclinical drug development and clinical drug development. Preclinical drug development includes the discovery process of the drug and clinical drug development includes three phases which are called as phase I, II & III.
Cardiovascular drugs are those which are used to treat the diseases related to heart. Development of a new drug which controls the diseases related to heart that is released into market after the discovery a active pharmaceutical ingredient is called Cardiovascular drug development.
Lead optimization is the process that is used to identify the compounds that are suitable for testing in a clinical setting. This is the process of identification of target sites during the drug discovery and development.
Formulation development is the process in which all the chemical substances including the active ingredient are used to develop a final medical product. Formulation development is the main process during the development of a drug.
Addiction is a condition in which an individual person gets addicted to alcohol or any other substance without which the person is not active. Research related to drug addiction is called a drug addiction research.
The research which is done to identify a new drug for the treatment of a disease and Drug discovery is the process of identifying a new a chemical or active pharmaceutical ingredient which is used for treating any particular disease is called as drug discovery.
It is an analytical chemistry method that helps identify the amount and type of chemicals present in a sample by measuring the mass-to-charge ratio. Ions are generated by inducing either the loss or gain of a charge from a neutral species.
Chromatography is one of the separation techniques that are used in industry to develop a new drug by following various analytical procedures. Development of new drugs requires that meaningful and reliable analytical data be generated at various steps of development. To assure the safety of a new pharmaceutical compound or drug requires various chromatography analyses
Natural products including plants, animals, and minerals have been the single most productive source of leads for the development of herbal medicine. A number of compounds derived from natural sources are currently undergoing clinical and preclinical studies for development of new drugs.
Biomarkers play an important role in medicine and have a greater role in drug discovery and development of a new drug. The challenge for biomarkers is to allow earlier, more robust drug safety and efficacy measurements in the development of a drug.
Translational medicine is defined as biomedical and public health research which aims to improve the individuals health and the community by "translating" findings into diagnostic tools, medicines, procedures, policies and education.
| Stability-Indicating Methods for the Determination of Gemifloxacin in
Presence of its Acid Degradation Product(s)
Author(s): Ezzat M. Abdel-Moety, Amr M. Badawey, Hebatallah M. Essam and Fatma M. Aboul Alamine
Abstract | PDF
| Therapeutic Potential of Brassica oleracea (Broccoli) - A Review
Author(s): Chandini Ravikumar
Abstract | PDF
| Synthesis, Characterization and Antibacterial Activity of a Novel Curcumin
Author(s): Anindya Bagchi, Prosenjit Mukherjee, Sarmistha Bhowmick and Anusree Raha
Abstract | PDF